VERANDA-SSc: study design of a phase III, randomised, placebo-controlled trial evaluating the efficacy and safety of oral nerandomilast treatment in systemic sclerosis

Anna-Maria Hoffmann-Vold, Oliver Distler, Yannick Allanore, Francesco Del Galdo, Christopher P Denton, Masataka Kuwana, Dinesh Khanna, Zsuzsanna H McMahan, Elizabeth R Volkmann, Hao Li, Mihaela Dumistracel, Martina Gahlemann, Susanne Stowasser, Shervin Assassi

Open source

DOI: 10.1136/jsrd-2026-000052
Published: 2026-07
Container: Journal of Scleroderma and Related Disorders
Publisher: BMJ
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jsrd-2026-000052,
  title = {VERANDA-SSc: study design of a phase III, randomised, placebo-controlled trial evaluating the efficacy and safety of oral nerandomilast treatment in systemic sclerosis},
  author = {Anna-Maria Hoffmann-Vold and Oliver Distler and Yannick Allanore and Francesco Del Galdo and Christopher P Denton and Masataka Kuwana and Dinesh Khanna and Zsuzsanna H McMahan and Elizabeth R Volkmann and Hao Li and Mihaela Dumistracel and Martina Gahlemann and Susanne Stowasser and Shervin Assassi},
  year = {2026},
  journal = {Journal of Scleroderma and Related Disorders},
  doi = {10.1136/jsrd-2026-000052},
  url = {https://doi.org/10.1136/jsrd-2026-000052}
}

RIS

TY  - JOUR
TI  - VERANDA-SSc: study design of a phase III, randomised, placebo-controlled trial evaluating the efficacy and safety of oral nerandomilast treatment in systemic sclerosis
AU  - Anna-Maria Hoffmann-Vold
AU  - Oliver Distler
AU  - Yannick Allanore
AU  - Francesco Del Galdo
AU  - Christopher P Denton
AU  - Masataka Kuwana
AU  - Dinesh Khanna
AU  - Zsuzsanna H McMahan
AU  - Elizabeth R Volkmann
AU  - Hao Li
AU  - Mihaela Dumistracel
AU  - Martina Gahlemann
AU  - Susanne Stowasser
AU  - Shervin Assassi
PY  - 2026
JO  - Journal of Scleroderma and Related Disorders
DO  - 10.1136/jsrd-2026-000052
UR  - https://doi.org/10.1136/jsrd-2026-000052
ER  -

APA

Hoffmann-Vold, A., Distler, O., Allanore, Y., Galdo, F. D., Denton, C. P., Kuwana, M., Khanna, D., McMahan, Z. H., Volkmann, E. R., Li, H., Dumistracel, M., Gahlemann, M., Stowasser, S., & Assassi, S. (2026). VERANDA-SSc: study design of a phase III, randomised, placebo-controlled trial evaluating the efficacy and safety of oral nerandomilast treatment in systemic sclerosis. Journal of Scleroderma and Related Disorders. https://doi.org/10.1136/jsrd-2026-000052

Source records

crossref · retrieved 2026-11-07T22:13:19.349Z